The Redox & Signaling Pharmaceutical Holdings Corporation is categorized under in Elmsford, NY and active since 2010.
The Redox & Signaling Pharmaceutical Holdings Corporation was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number by the NAICS.
If you are seeking more information, feel free to contact Harry Demopoulos at the company’s single location by writing to 8 Westchester Plaza # 133, Elmsford, New York NY 10523 or by phoning (914) 592-3155. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | The Redox & Signaling Pharmaceutical Holdings Corporation |
Contact Person: | Harry Demopoulos |
Address: | 8 Westchester Plaza # 133, Elmsford, New York 10523 |
Phone Number: | (914) 592-3155 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | |
Share This Business: |
The Redox & Signaling Pharmaceutical Holdings Corporation was started in 2010 to provide professional under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Harry Demopoulos for inquiries that concern The Redox & Signaling Pharmaceutical Holdings Corporation by calling the company number (914) 592-3155, as your correspondence is most welcome. Additionally, the physical location of the single location of The Redox & Signaling Pharmaceutical Holdings Corporation can be found at the coordinates 41.06707,-73.8141 as well as the street address 8 Westchester Plaza # 133 in Elmsford, New York 10523.
For its online presence, you may visit The Redox & Signaling Pharmaceutical Holdings Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.